Plain-English translation of NCT05885932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two approaches for treating vertebral artery stenosis—a serious narrowing of a major blood vessel in your neck that supplies your brain. Half of participants will receive a sirolimus-eluting stent (a tiny mesh tube coated with medication) placed in the narrowed artery, plus medication to prevent blood clots. The other half will receive the same clot-prevention medications without the stent procedure.
About one in four strokes affecting the back of the brain is caused by vertebral artery narrowing, and doctors aren't yet certain whether adding a stent to medication helps more than medication alone. Two earlier trials were too small to answer this question, so this larger, well-designed study aims to find the best treatment approach.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to either the stent group or the medication-only group. If you are assigned to receive a stent, you will undergo a procedure to place the sirolimus-eluting stent in your narrowed vertebral artery. Both groups will take dual blood-thinning medications for 6 months, then a single medication thereafter. You will have follow-up visits and assessments at regular intervals throughout the first year, with additional long-term follow-ups planned for up to 3 years or longer to track your health and monitor for any stroke recurrence.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
China